Looking for Doxorubicin found 9 matches
|
| Open monograph to display formulary status |
BNF Category |
| |
 Doxorubicin
|
Malignant disease and immunosuppression - Anthracyclines and other cytotoxic antibiotics - 08.01.02
|
| |
Brentuximab vedotin
(Adcetris®)
|
Malignant disease and immunosuppression - Brentuximab vedotin - 08.01.05
|
| |
Gemcitabine
|
Malignant disease and immunosuppression - Antimetabolites - 08.01.03
|
| |
Polatuzumab vedotin
(Polivy®)
|
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
|
| |
Links Link to Drug Section  Link to document |
|
NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
|
|
NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
|
|
NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
|
|
NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.02)
|
|
NICE TA389: Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.03)
|
|
|
